Market Name: Doxil

Generic Name: Doxorubicin HCl

Special attention must be given to the myocardial damage that may be associated with cumulative doses of doxorubicin HCl. Acute left ventricular failure may occur with doxorubicin. Can also cause myelosuppression, infusion reactions and hand-foot syndrome.

Black Box Warning Date: January 2005

FDA Link: Doxil